VeTVISC 2.0 %

2.0% high-molecular-weight hyaluronic acid viscoelastic solution.

Maintenance of anterior chamber space and protection of the corneal endothelium and adjacent tissues

Concentration: 2.0%
Presentation (format): 1.2 mL prefilled syringe + injection cannula
Certification: Veterinary health material and equipment product
Recommended needle: 25G
Shelf life: 2 years
Technology: Linear sodium hyaluronate hydrogel.

Buen perfil de seguridad

Advantages

Low endotoxin content.

No refrigeration required.

HA obtained through biofermentation.

Indications

Indicated as an adjunct during surgical procedures involving the anterior chamber of the eye, particularly cataract surgery, including lens extraction and intraocular lens insertion.

Properties

Protects intraocular tissues, facilitating surgery.

Maintains the depth and integrity of the anterior chamber of the eye, facilitating surgery.

Facilitates insertion of the intraocular lens.

Provides excellent visibility of the surgical field.

Directions for use

For administration only by healthcare professionals specialising in ophthalmology, in accordance with all rules governing aseptic procedure and injection technique to ensure treatment safety and efficacy.

Technology

Linear sodium hyaluronate hydrogel.